[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Liver Medicine Market Size, Status and Forecast 2020-2026

August 2020 | 98 pages | ID: G3CFABF9F073EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Liver Medicine market is segmented by Type, and by Sales Channel. Players, stakeholders, and other participants in the global Liver Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Sales Channel in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
  • Pfizer
  • Roche
  • Sanofi
  • Novartis
  • Amgen
  • Xiuzheng Pharmaceutical Group
  • Xiaolin Zhiyao
  • Henan Lingrui Pharmaceutical
  • Kuihua yaoye
  • Sanjiu Pharmaceutical
  • Harbin Pharmaceutical Group
Market segment by Type, the product can be split into
  • Tablet
  • Capsule
  • Oral Liquid
Market segment by Sales Channel, split into
  • Hospital
  • Pharmacy
  • Others
Market segment by Regions/Countries, this report covers
  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Liver Medicine Revenue
1.4 Market by Type
  1.4.1 Global Liver Medicine Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Tablet
  1.4.3 Capsule
  1.4.4 Oral Liquid
1.5 Market by Application
  1.5.1 Global Liver Medicine Market Share by Sales Channel: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Pharmacy
  1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Liver Medicine Market Perspective (2015-2026)
2.2 Global Liver Medicine Growth Trends by Regions
  2.2.1 Liver Medicine Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Liver Medicine Historic Market Share by Regions (2015-2020)
  2.2.3 Liver Medicine Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Liver Medicine Market Growth Strategy
  2.3.6 Primary Interviews with Key Liver Medicine Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Liver Medicine Players by Market Size
  3.1.1 Global Top Liver Medicine Players by Revenue (2015-2020)
  3.1.2 Global Liver Medicine Revenue Market Share by Players (2015-2020)
  3.1.3 Global Liver Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Liver Medicine Market Concentration Ratio
  3.2.1 Global Liver Medicine Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Liver Medicine Revenue in 2019
3.3 Liver Medicine Key Players Head office and Area Served
3.4 Key Players Liver Medicine Product Solution and Service
3.5 Date of Enter into Liver Medicine Market
3.6 Mergers & Acquisitions, Expansion Plans

4 MARKET SIZE BY TYPE (2015-2026)

4.1 Global Liver Medicine Historic Market Size by Type (2015-2020)
4.2 Global Liver Medicine Forecasted Market Size by Type (2021-2026)

5 MARKET SIZE BY SALES CHANNEL (2015-2026)

5.1 Global Liver Medicine Market Size by Sales Channel (2015-2020)
5.2 Global Liver Medicine Forecasted Market Size by Sales Channel (2021-2026)

6 NORTH AMERICA

6.1 North America Liver Medicine Market Size (2015-2020)
6.2 Liver Medicine Key Players in North America (2019-2020)
6.3 North America Liver Medicine Market Size by Type (2015-2020)
6.4 North America Liver Medicine Market Size by Sales Channel (2015-2020)

7 EUROPE

7.1 Europe Liver Medicine Market Size (2015-2020)
7.2 Liver Medicine Key Players in Europe (2019-2020)
7.3 Europe Liver Medicine Market Size by Type (2015-2020)
7.4 Europe Liver Medicine Market Size by Sales Channel (2015-2020)

8 CHINA

8.1 China Liver Medicine Market Size (2015-2020)
8.2 Liver Medicine Key Players in China (2019-2020)
8.3 China Liver Medicine Market Size by Type (2015-2020)
8.4 China Liver Medicine Market Size by Sales Channel (2015-2020)

9 JAPAN

9.1 Japan Liver Medicine Market Size (2015-2020)
9.2 Liver Medicine Key Players in Japan (2019-2020)
9.3 Japan Liver Medicine Market Size by Type (2015-2020)
9.4 Japan Liver Medicine Market Size by Sales Channel (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Liver Medicine Market Size (2015-2020)
10.2 Liver Medicine Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Liver Medicine Market Size by Type (2015-2020)
10.4 Southeast Asia Liver Medicine Market Size by Application (2015-2020)

11 INDIA

11.1 India Liver Medicine Market Size (2015-2020)
11.2 Liver Medicine Key Players in India (2019-2020)
11.3 India Liver Medicine Market Size by Type (2015-2020)
11.4 India Liver Medicine Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Liver Medicine Market Size (2015-2020)
12.2 Liver Medicine Key Players in Central & South America (2019-2020)
12.3 Central & South America Liver Medicine Market Size by Type (2015-2020)
12.4 Central & South America Liver Medicine Market Size by Application (2015-2020)

13KEY PLAYERS PROFILES

13.1 Pfizer
  13.1.1 Pfizer Company Details
  13.1.2 Pfizer Business Overview
  13.1.3 Pfizer Liver Medicine Introduction
  13.1.4 Pfizer Revenue in Liver Medicine Business (2015-2020))
  13.1.5 Pfizer Recent Development
13.2 Roche
  13.2.1 Roche Company Details
  13.2.2 Roche Business Overview
  13.2.3 Roche Liver Medicine Introduction
  13.2.4 Roche Revenue in Liver Medicine Business (2015-2020)
  13.2.5 Roche Recent Development
13.3 Sanofi
  13.3.1 Sanofi Company Details
  13.3.2 Sanofi Business Overview
  13.3.3 Sanofi Liver Medicine Introduction
  13.3.4 Sanofi Revenue in Liver Medicine Business (2015-2020)
  13.3.5 Sanofi Recent Development
13.4 Novartis
  13.4.1 Novartis Company Details
  13.4.2 Novartis Business Overview
  13.4.3 Novartis Liver Medicine Introduction
  13.4.4 Novartis Revenue in Liver Medicine Business (2015-2020)
  13.4.5 Novartis Recent Development
13.5 Amgen
  13.5.1 Amgen Company Details
  13.5.2 Amgen Business Overview
  13.5.3 Amgen Liver Medicine Introduction
  13.5.4 Amgen Revenue in Liver Medicine Business (2015-2020)
  13.5.5 Amgen Recent Development
13.6 Xiuzheng Pharmaceutical Group
  13.6.1 Xiuzheng Pharmaceutical Group Company Details
  13.6.2 Xiuzheng Pharmaceutical Group Business Overview
  13.6.3 Xiuzheng Pharmaceutical Group Liver Medicine Introduction
  13.6.4 Xiuzheng Pharmaceutical Group Revenue in Liver Medicine Business (2015-2020)
  13.6.5 Xiuzheng Pharmaceutical Group Recent Development
13.7 Xiaolin Zhiyao
  13.7.1 Xiaolin Zhiyao Company Details
  13.7.2 Xiaolin Zhiyao Business Overview
  13.7.3 Xiaolin Zhiyao Liver Medicine Introduction
  13.7.4 Xiaolin Zhiyao Revenue in Liver Medicine Business (2015-2020)
  13.7.5 Xiaolin Zhiyao Recent Development
13.8 Henan Lingrui Pharmaceutical
  13.8.1 Henan Lingrui Pharmaceutical Company Details
  13.8.2 Henan Lingrui Pharmaceutical Business Overview
  13.8.3 Henan Lingrui Pharmaceutical Liver Medicine Introduction
  13.8.4 Henan Lingrui Pharmaceutical Revenue in Liver Medicine Business (2015-2020)
  13.8.5 Henan Lingrui Pharmaceutical Recent Development
13.9 Kuihua yaoye
  13.9.1 Kuihua yaoye Company Details
  13.9.2 Kuihua yaoye Business Overview
  13.9.3 Kuihua yaoye Liver Medicine Introduction
  13.9.4 Kuihua yaoye Revenue in Liver Medicine Business (2015-2020)
  13.9.5 Kuihua yaoye Recent Development
13.10 Sanjiu Pharmaceutical
  13.10.1 Sanjiu Pharmaceutical Company Details
  13.10.2 Sanjiu Pharmaceutical Business Overview
  13.10.3 Sanjiu Pharmaceutical Liver Medicine Introduction
  13.10.4 Sanjiu Pharmaceutical Revenue in Liver Medicine Business (2015-2020)
  13.10.5 Sanjiu Pharmaceutical Recent Development
13.11 Harbin Pharmaceutical Group
  10.11.1 Harbin Pharmaceutical Group Company Details
  10.11.2 Harbin Pharmaceutical Group Business Overview
  10.11.3 Harbin Pharmaceutical Group Liver Medicine Introduction
  10.11.4 Harbin Pharmaceutical Group Revenue in Liver Medicine Business (2015-2020)
  10.11.5 Harbin Pharmaceutical Group Recent Development

14ANALYST'S VIEWPOINTS/CONCLUSIONS

15APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES

Table 1. Liver Medicine Key Market Segments
Table 2. Key Players Covered: Ranking by Liver Medicine Revenue
Table 3. Ranking of Global Top Liver Medicine Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Liver Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Tablet
Table 6. Key Players of Capsule
Table 7. Key Players of Oral Liquid
Table 8. Global Liver Medicine Market Size Growth by Sales Channel (US$ Million): 2020 VS 2026
Table 9. Global Liver Medicine Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Liver Medicine Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Liver Medicine Market Share by Regions (2015-2020)
Table 12. Global Liver Medicine Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Liver Medicine Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Liver Medicine Market Growth Strategy
Table 18. Main Points Interviewed from Key Liver Medicine Players
Table 19. Global Liver Medicine Revenue by Players (2015-2020) (Million US$)
Table 20. Global Liver Medicine Market Share by Players (2015-2020)
Table 21. Global Top Liver Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liver Medicine as of 2019)
Table 22. Global Liver Medicine by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Liver Medicine Product Solution and Service
Table 25. Date of Enter into Liver Medicine Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Liver Medicine Market Size by Type (2015-2020) (Million US$)
Table 28. Global Liver Medicine Market Size Share by Type (2015-2020)
Table 29. Global Liver Medicine Revenue Market Share by Type (2021-2026)
Table 30. Global Liver Medicine Market Size Share by Sales Channel (2015-2020)
Table 31. Global Liver Medicine Market Size by Sales Channel (2015-2020) (Million US$)
Table 32. Global Liver Medicine Market Size Share by Sales Channel (2021-2026)
Table 33. North America Key Players Liver Medicine Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Liver Medicine Market Share (2019-2020)
Table 35. North America Liver Medicine Market Size by Type (2015-2020) (Million US$)
Table 36. North America Liver Medicine Market Share by Type (2015-2020)
Table 37. North America Liver Medicine Market Size by Sales Channel (2015-2020) (Million US$)
Table 38. North America Liver Medicine Market Share by Sales Channel (2015-2020)
Table 39. Europe Key Players Liver Medicine Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Liver Medicine Market Share (2019-2020)
Table 41. Europe Liver Medicine Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Liver Medicine Market Share by Type (2015-2020)
Table 43. Europe Liver Medicine Market Size by Sales Channel (2015-2020) (Million US$)
Table 44. Europe Liver Medicine Market Share by Sales Channel (2015-2020)
Table 45. China Key Players Liver Medicine Revenue (2019-2020) (Million US$)
Table 46. China Key Players Liver Medicine Market Share (2019-2020)
Table 47. China Liver Medicine Market Size by Type (2015-2020) (Million US$)
Table 48. China Liver Medicine Market Share by Type (2015-2020)
Table 49. China Liver Medicine Market Size by Sales Channel (2015-2020) (Million US$)
Table 50. China Liver Medicine Market Share by Sales Channel (2015-2020)
Table 51. Japan Key Players Liver Medicine Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Liver Medicine Market Share (2019-2020)
Table 53. Japan Liver Medicine Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Liver Medicine Market Share by Type (2015-2020)
Table 55. Japan Liver Medicine Market Size by Sales Channel (2015-2020) (Million US$)
Table 56. Japan Liver Medicine Market Share by Sales Channel (2015-2020)
Table 57. Southeast Asia Key Players Liver Medicine Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Liver Medicine Market Share (2019-2020)
Table 59. Southeast Asia Liver Medicine Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Liver Medicine Market Share by Type (2015-2020)
Table 61. Southeast Asia Liver Medicine Market Size by Sales Channel (2015-2020) (Million US$)
Table 62. Southeast Asia Liver Medicine Market Share by Sales Channel (2015-2020)
Table 63. India Key Players Liver Medicine Revenue (2019-2020) (Million US$)
Table 64. India Key Players Liver Medicine Market Share (2019-2020)
Table 65. India Liver Medicine Market Size by Type (2015-2020) (Million US$)
Table 66. India Liver Medicine Market Share by Type (2015-2020)
Table 67. India Liver Medicine Market Size by Sales Channel (2015-2020) (Million US$)
Table 68. India Liver Medicine Market Share by Sales Channel (2015-2020)
Table 69. Central & South America Key Players Liver Medicine Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Liver Medicine Market Share (2019-2020)
Table 71. Central & South America Liver Medicine Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Liver Medicine Market Share by Type (2015-2020)
Table 73. Central & South America Liver Medicine Market Size by Sales Channel (2015-2020) (Million US$)
Table 74. Central & South America Liver Medicine Market Share by Sales Channel (2015-2020)
Table 75. Pfizer Company Details
Table 76. Pfizer Business Overview
Table 77. Pfizer Product
Table 78. Pfizer Revenue in Liver Medicine Business (2015-2020) (Million US$)
Table 79. Pfizer Recent Development
Table 80. Roche Company Details
Table 81. Roche Business Overview
Table 82. Roche Product
Table 83. Roche Revenue in Liver Medicine Business (2015-2020) (Million US$)
Table 84. Roche Recent Development
Table 85. Sanofi Company Details
Table 86. Sanofi Business Overview
Table 87. Sanofi Product
Table 88. Sanofi Revenue in Liver Medicine Business (2015-2020) (Million US$)
Table 89. Sanofi Recent Development
Table 90. Novartis Company Details
Table 91. Novartis Business Overview
Table 92. Novartis Product
Table 93. Novartis Revenue in Liver Medicine Business (2015-2020) (Million US$)
Table 94. Novartis Recent Development
Table 95. Amgen Company Details
Table 96. Amgen Business Overview
Table 97. Amgen Product
Table 98. Amgen Revenue in Liver Medicine Business (2015-2020) (Million US$)
Table 99. Amgen Recent Development
Table 100. Xiuzheng Pharmaceutical Group Company Details
Table 101. Xiuzheng Pharmaceutical Group Business Overview
Table 102. Xiuzheng Pharmaceutical Group Product
Table 103. Xiuzheng Pharmaceutical Group Revenue in Liver Medicine Business (2015-2020) (Million US$)
Table 104. Xiuzheng Pharmaceutical Group Recent Development
Table 105. Xiaolin Zhiyao Company Details
Table 106. Xiaolin Zhiyao Business Overview
Table 107. Xiaolin Zhiyao Product
Table 108. Xiaolin Zhiyao Revenue in Liver Medicine Business (2015-2020) (Million US$)
Table 109. Xiaolin Zhiyao Recent Development
Table 110. Henan Lingrui Pharmaceutical Business Overview
Table 111. Henan Lingrui Pharmaceutical Product
Table 112. Henan Lingrui Pharmaceutical Company Details
Table 113. Henan Lingrui Pharmaceutical Revenue in Liver Medicine Business (2015-2020) (Million US$)
Table 114. Henan Lingrui Pharmaceutical Recent Development
Table 115. Kuihua yaoye Company Details
Table 116. Kuihua yaoye Business Overview
Table 117. Kuihua yaoye Product
Table 118. Kuihua yaoye Revenue in Liver Medicine Business (2015-2020) (Million US$)
Table 119. Kuihua yaoye Recent Development
Table 120. Sanjiu Pharmaceutical Company Details
Table 121. Sanjiu Pharmaceutical Business Overview
Table 122. Sanjiu Pharmaceutical Product
Table 123. Sanjiu Pharmaceutical Revenue in Liver Medicine Business (2015-2020) (Million US$)
Table 124. Sanjiu Pharmaceutical Recent Development
Table 125. Harbin Pharmaceutical Group Company Details
Table 126. Harbin Pharmaceutical Group Business Overview
Table 127. Harbin Pharmaceutical Group Product
Table 128. Harbin Pharmaceutical Group Revenue in Liver Medicine Business (2015-2020) (Million US$)
Table 129. Harbin Pharmaceutical Group Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global Liver Medicine Market Share by Type: 2020 VS 2026
Figure 2. Tablet Features
Figure 3. Capsule Features
Figure 4. Oral Liquid Features
Figure 5. Global Liver Medicine Market Share by Sales Channel: 2020 VS 2026
Figure 6. Hospital Case Studies
Figure 7. Pharmacy Case Studies
Figure 8. Others Case Studies
Figure 9. Liver Medicine Report Years Considered
Figure 10. Global Liver Medicine Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Liver Medicine Market Share by Regions: 2020 VS 2026
Figure 12. Global Liver Medicine Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Liver Medicine Market Share by Players in 2019
Figure 15. Global Top Liver Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liver Medicine as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Liver Medicine Revenue in 2019
Figure 17. North America Liver Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Liver Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Liver Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Liver Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Liver Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Liver Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Liver Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed


More Publications